A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
AstraZeneca PLC Τιμή δεδομένων σε πραγματικό χρόνο
The current price of AstraZeneca PLC in the market is 169,81 €, with a 24-hour trading volume of 219,28M €. The asset's market cap is 263,23B €, after moving -2.40% in the last day.
Tokenized AstraZeneca PLC is trading at 84,97 €, with a tokenized market cap of 637,31K € and a 24-hour trading volume of 585,53K €. The tokenized asset has moved -1.90% in the past 24 hours.